MANILA, May 31 (Mabuhay) — The Food and Drug Administration has approved the use of Moderna’s COVID-19 vaccine for children ages 6 to 11, the Department of Health said Tuesday.

The regulatory body amended the emergency use authorization for Moderna’s coronavirus jab to include the said age group on May 20, according to the DOH.

The Health Technology Assessment Council must give a positive recommendation before the vaccine can be rolled out, said Dr. Beverly Ho, director of the DOH Health Promotion bureau.

Two doses of Moderna’s Spikevax vaccine elicit “strong immune response” for children ages 6 to 12, said its Philippine distributor Zuellig Pharma Corporation in a statement Monday. The safety and efficacy of the vaccine are similar to those in adults, it added.

“The Spikevax COVID-19 Vaccine Moderna boosts opportunities in ensuring more children are protected against the virus,” said Dr. Philip Nakpil, medical director of Zuellig Pharma Corporation.

The FDA earlier approved the use of Pfizer’s reformulated jab for children ages 5 to 11, and Sinovac’s COVID-19 vaccine for ages 6 and above. (MNS)

READ NEXT: Philippines logs 200 new COVID-19 infections